Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 283
6
Diseases
33
Unique genes
0.087
Avg. similarity score
Adrenal gland neoplasms
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Adrenal gland neoplasms
Corneal disease
Corneal edema
pitt-hopkins syndrome
Paranoia
White spongue nevus
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Adrenal gland neoplasms | 4 | 4 | 7 |
| Corneal disease | 4 | 4 | 12 |
| Corneal edema | 4 | 4 | 4 |
| pitt-hopkins syndrome | 4 | 4 | 1 |
| Paranoia | 3 | 3 | 12 |
| White spongue nevus | 1 | 1 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TCF4 | 5 / 6 | Adrenal gland neoplasms, Corneal disease, Corneal edema, Paranoia and 1 more |
| KRT4 | 2 / 6 | Corneal disease, White spongue nevus |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| MET activates PTK2 signaling | Reactome | 3 / 30 | 36.4× | 7.30e-5 | 1.73e-3 ✓ sig. |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | Reactome | 2 / 15 | 48.5× | 7.52e-4 | 1.10e-2 ✓ sig. |
| IL-6-type cytokine receptor ligand interactions | Reactome | 2 / 17 | 42.8× | 9.70e-4 | 1.33e-2 ✓ sig. |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | Reactome | 2 / 24 | 30.3× | 1.95e-3 | 2.23e-2 ✓ sig. |
| Dopamine clearance from the synaptic cleft | Reactome | 1 / 1 | 364× | 2.75e-3 | 2.89e-2 ✓ sig. |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | Reactome | 1 / 1 | 364× | 2.75e-3 | 2.89e-2 ✓ sig. |
| Th17 cell differentiation | KEGG | 3 / 109 | 10.0× | 3.25e-3 | 3.26e-2 ✓ sig. |
| Toxoplasmosis | KEGG | 3 / 112 | 9.7× | 3.51e-3 | 3.43e-2 ✓ sig. |
| Allograft rejection | KEGG | 2 / 39 | 18.7× | 5.09e-3 | 4.43e-2 ✓ sig. |
| Formation of the cornified envelope | Reactome | 3 / 130 | 8.4× | 5.33e-3 | 4.57e-2 ✓ sig. |
| N-glycan trimming and elongation in the cis-Golgi | Reactome | 1 / 2 | 182× | 5.49e-3 | 4.65e-2 ✓ sig. |
| Type I diabetes mellitus | KEGG | 2 / 44 | 16.5× | 6.44e-3 | 5.18e-2 |
| Collagen chain trimerization | Reactome | 2 / 44 | 16.5× | 6.44e-3 | 5.18e-2 |
| Graft-versus-host disease | KEGG | 2 / 45 | 16.2× | 6.73e-3 | 5.32e-2 |
| Keratinization | Reactome | 3 / 152 | 7.2× | 8.21e-3 | 6.07e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| dopamine catabolic process | GO:0042420 | 2 / 11 | 103× | 1.65e-4 | 4.39e-3 ✓ sig. |
| intermediate filament organization | GO:0045109 | 3 / 70 | 24.3× | 2.53e-4 | 5.98e-3 ✓ sig. |
| maternal behavior | GO:0042711 | 2 / 14 | 80.9× | 2.72e-4 | 6.26e-3 ✓ sig. |
| response to pain | GO:0048265 | 2 / 19 | 59.6× | 5.08e-4 | 9.66e-3 ✓ sig. |
| epithelial cell differentiation | GO:0030855 | 3 / 110 | 15.4× | 9.52e-4 | 1.47e-2 ✓ sig. |
| integrin biosynthetic process | GO:0045112 | 1 / 1 | 566× | 1.77e-3 | 2.11e-2 ✓ sig. |
| glycolate metabolic process | GO:0009441 | 1 / 1 | 566× | 1.77e-3 | 2.11e-2 ✓ sig. |
| muscle hypertrophy | GO:0014896 | 1 / 1 | 566× | 1.77e-3 | 2.11e-2 ✓ sig. |
| negative regulation of oocyte development | GO:0060283 | 1 / 1 | 566× | 1.77e-3 | 2.11e-2 ✓ sig. |
| regulation of vascular associated smooth muscle cell proliferation | GO:1904705 | 1 / 1 | 566× | 1.77e-3 | 2.11e-2 ✓ sig. |
| neuronal-glial interaction involved in cerebral cortex radial glia guided migration | GO:0021812 | 1 / 1 | 566× | 1.77e-3 | 2.11e-2 ✓ sig. |
| associative learning | GO:0008306 | 2 / 40 | 28.3× | 2.26e-3 | 2.42e-2 ✓ sig. |
| blood vessel remodeling | GO:0001974 | 2 / 42 | 27.0× | 2.49e-3 | 2.56e-2 ✓ sig. |
| antigen processing and presentation | GO:0019882 | 2 / 48 | 23.6× | 3.24e-3 | 2.94e-2 ✓ sig. |
| negative regulation of endodermal cell differentiation | GO:1903225 | 1 / 2 | 283× | 3.53e-3 | 3.08e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Corneal edema | pitt-hopkins syndrome | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Adrenal gland neoplasms | pitt-hopkins syndrome | 0.125 | 1 | 4.55e-4 | 9.55e-4 ✓ sig. |
| Corneal disease | pitt-hopkins syndrome | 0.077 | 1 | 7.79e-4 | 1.39e-3 ✓ sig. |
| Paranoia | pitt-hopkins syndrome | 0.077 | 1 | 7.79e-4 | 1.39e-3 ✓ sig. |
| Corneal disease | White spongue nevus | 0.071 | 1 | 1.56e-3 | 2.36e-3 ✓ sig. |
| Adrenal gland neoplasms | Corneal edema | 0.091 | 1 | 1.82e-3 | 2.66e-3 ✓ sig. |
| Corneal disease | Corneal edema | 0.063 | 1 | 3.11e-3 | 4.09e-3 ✓ sig. |
| Corneal edema | Paranoia | 0.063 | 1 | 3.11e-3 | 4.09e-3 ✓ sig. |
| Adrenal gland neoplasms | Corneal disease | 0.053 | 1 | 5.44e-3 | 6.63e-3 ✓ sig. |
| Adrenal gland neoplasms | Paranoia | 0.053 | 1 | 5.44e-3 | 6.63e-3 ✓ sig. |